Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Tirzepatide associated with greater weight loss in women than men

Written by | 1 Oct 2024

All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but women experienced… read more.

Survey shows 25% of adults consider weight loss drug use without prescription

Written by | 23 Sep 2024

Injectable weight loss drugs are popular right now but can be hard to get because they are in short supply or too expensive without insurance. The result is… read more.

Semaglutide and tirzepatide treatment leads to weight loss in type 1 diabetes

Written by | 14 Sep 2024

Treatment with semaglutide and tirzepatide led to significant weight loss and improved blood sugar control in overweight or obese patients with type 1 diabetes (T1D). Researchers reported this… read more.

Clinical trial in Ireland challenges beliefs about Ozempic and similar new obesity treatments

Written by | 30 Aug 2024

A study carried out in St Vincent’s University Hospital (SVUH) Dublin challenges the belief that weight loss medications such as Ozempic, Wegovy or Monjaro work just by promoting… read more.

High BMI eligibility for semaglutide could cost Medicare an additional $145 billion annually

Written by | 30 Aug 2024

A brief research report found that 61% of Medicare-eligible adults have a BMI of 27 or higher, which means they may benefit from a GLP-1 receptor agonist like… read more.

Vegan diet better than Mediterranean diet for weight loss and reducing harmful inflammatory dietary compounds, finds new research

Written by | 11 Aug 2024

Eating a low-fat vegan diet reduces harmful inflammatory dietary compounds called advanced glycation end-products (AGEs) by 73%, compared to no reduction on a Mediterranean diet, according to new… read more.

Data shows surge in in new GLP-1RA prescriptions for obesity without type 2 diabetes

Written by | 25 Jul 2024

A nationwide study found a marked increase in new GLP-1RA prescriptions over the last decade, particularly since 2020. Semaglutide was the most prescribed GLP-1RA, by far, in 2023…. read more.

Specialist weight-loss services in England unable to keep up with spiralling demand

Written by | 20 Jun 2024

One in six integrated care boards (ICBs) in England have stopped accepting new patients for specialist weight management services as their referral numbers spiral out of control, an… read more.

Adding obesity experts to primary care clinics improves patients’ weight loss outcomes

Written by | 24 May 2024

Giving high-risk patients access to an obesity specialist through their regular primary care clinic increased their chances of receiving at least one evidence-based weight-management treatment, and led to… read more.

Few newly diagnosed type 2 diabetics succeed in losing weight – weight gain linked to much higher risk of complications

Written by | 11 Apr 2024

A register-based study from Finland identified three distinct BMI trajectory groups among patients with newly diagnosed type 2 diabetes. In a four-year follow-up, most patients followed a stable… read more.

Replacing sugar with sweeteners can improve weight loss control over the long-term in adults in the overweight range, finds European randomised controlled trial

Written by | 26 Mar 2024

New research being presented at this year’s European Congress on Obesity (ECO) in Venice, Italy (12-15 May), suggests that replacing sugar-sweetened food and drinks with low/no energy sweetened… read more.

Very low calorie diets are safe and acceptable for teenagers with moderate to severe obesity when used short-term and supported by a dietitian, Australian study finds

Written by | 22 Mar 2024

Short-term very low calorie diets are safe for teenagers living with moderate to severe obesity when closely monitored by an experienced dietitian, new research to be presented at… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.